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 Worldwide problem
 Unknown, signs are increasing – 30,000
 All Party Parliamentary Drugs Misuse Group- APPDMG 2007-
2008
 No reliable figures – DH trying to address now
 Scotland study 5/week potential misusers
 Not much written about it
 On-line pharmacies
Who takes?
 Older adults
 More ‘middle aged’ women
 ‘Respectable addiction’
◦ Adolescents
◦ Healthcare professionals
 Self-medication
◦ To treat minor ailment, don’t want to bother doctor
 Start as prescription drug 
◦ e.g. post-op pain
 Top up prescription drug 
◦ e.g. not enough for chronic pain
 Back and forth between the two

What do people take?
 Codeine based products
 Decongestants
 Cough mixtures
 Antihistamines
 Laxatives 
 Combinations: Nytol (diphenhydramine and 
antihistamine)
 Caffeine and weight loss stimulants 
 Codeine (42 prods) and dihydrocodeine (4) are analgesics and 
cough suppressants
 Containing in many OTC medicines
◦ Codeine 42 products, 36 with paracetamol, 2 ibuprofen, 4 aspirin
◦ Dihydrocodeine 4 products, all with paracetamol 
 Maximum dose: 
◦ Codeine 25.6mg / dose (12.8mg / tablet)
◦ DHC 14.92mg / dose (7.46mg /tablet)
 Some also in combination with:
◦ Caffeine
NB: The body converts codeine into morphine so its effects 
are similar, if less intense.

 Solpadeine Plus: combination of codeine (8mg) paracetamol 
(500mg) and caffeine (30mg) 
 Nufrofen Plus: combination of codeine (12.8mg)  and ibuprofen 
(200mg)
 Generic co-codamol: codeine (8mg) and paracetamol (500mg)
 Syndol: codeine (10mg) paracetamol (450mg) caffeine (30mg) 
and doxylamine succinate (5mg)  
 Feminax Express tablet: codeine (8mg) paracetamol (500mg) 
and  ibuprofen lysine (342mg equivalent to 200mg ibuprofen) 
Used to contain Hyoscine Hydrobromide (0.1mg) and Caffeine 
(50mg) 
Will making codeine more difficult to 
access help the problem ?
 Guidelines by the MHRA on codeine prescribing 
3.9.09
◦ Indications- Short term only
◦ Acute/moderate pain-not relieved by 
paracetamol/ibuprofen/aspirin alone
 Patient information leaflets- PIL and Labels
◦ Short term only, up to 3 days
◦ Can cause addiction and /or overuse headaches
 Pack Size- maximum 32, paracetamol 16
 Advertisements
◦ Can cause addiction, for 3 days only
◦ Removal of any references to pain killing power or strength

 Used for illicit manufacture of methylamphetamine 
 Limited number of packs / transaction to one
 Major pharmacy chain show 26% drop in number of 
tablets sold between July 2008 – August 2009

 Caffeine stimulants 
 Antihistamines like Benadryl containing dyphenhydramine 
 Decongestants like Sudafed containing pseudoephedrine 
 Weight loss supplements containing ma haung or ephedra 
 Sleep aids containing doxylamine, like Unisom, etc. 
 Motion sickness treatments with dimenhydrinates, like Dramamine 
 Teens think abusing common OTC medicines is safer than using illicit 
drugs
 10 percent of teens (2.4 million) report abusing cough medicine to get 
high
Potential harms
 Psychological – shame
◦ hidden problem, unable to get help
 Effect of dependency on self, family and 
others
◦ e.g. depression, loss of work
 Lapse into another addiction
◦ e.g. alcohol, opioids
 Physical consequences of active ingredient
◦ e.g. codeine, constipation
 Physical consequences of another ingredient
◦ e.g. ibuprofen: bleed
 Can have dependency along with mental health 
problems
 Self-medication psychological or physical
 Between 10-25% say start opiates cause of pain 
 Prevalence chronic pain is 30-50% in treated 
substance users, compared with 10-15% of the 
general population
What happens when go for help?
 Over Count Study
◦ those patients who approached there GPs saying 
that they felt they had a problem didn’t get the 
help and support they required
Why getting help difficult to get?
 Poorly recognised problem by clinicians and 
patients
 Misunderstood and hidden problem
 Lack training and guidance
Three parts:
1. Psychological support
2. Prescribing
3. Groups – local or internet based
 CBT
 Motivational interviewing
 Behavioural change
 International Treatment Effectiveness Project (ITEP)
 List benefits and adverse things that get from using
 Keep drug diary of use for 1-2 weeks
 Engage with support
 Explain tolerance
 Methadone
 Buprenorphine
 Dihydrocodeine 
 Codeine 
 Morphine (MST, MXL)
 Not exact, need to titrate
DRUG EQUIV 10mg METHADONE
Buprenorphine = 2-4mg?
Dihydrocodeine = 60-120mg (in 2 doses)
Codeine = 40-120mg (divided 2)
Morphine (MST, MXL) = 60-90 mg 
 Detoxification or maintenance
 Same principles:
◦ Titrate until steady
◦ Reduce at patient speed
 Support same time
 Dihydrocodeine and codeine more effective?
 Survey on ‘Overcount’
◦ Success rate with methadone / buprenorphine around the 
26% mark i.e. 3/4 of people who try or are given this 
method, fail within the initial 4-6 weeks
◦ Structured gradual Withdrawal Programme, based on the 
actual OTC product which they have been misusing, the 
success rate rises to over 80%, i.e. 4 out of 5 people 
succeed in quitting their habit
 All programmes dependant on:
◦ length of time that the person has had the addiction
◦ daily dose
 Why might methadone / buprenorphine be less successful?
 Internet based
◦ Codeine-free codeinefree.me.uk
◦ Overcount 
myweb.tiscali.co.uk/overcount/index.htm
 Local groups
 Unrecognised problem, size unknown but increasing
 Evidence leaves scope for further research
 Little guidance and training
 But many things can do to help
 Don’t forget: psychological help, prescribing and group 
support
 And detox if part of the process not the end
 Important GPS ,Pharmacists and all health care professionals 
are educated about this problem
 Need for most help and services for people who have 
problematic OTC use
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